The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine ...Middle East

CHENGDU, China, April 5, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its independently developed IL-4Rα antibody...

Hence then, the article about the phase iii study data of stapokibart for seasonal allergic rhinitis published in nature medicine was published today ( Saturday 05/04/2025 - 05:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine )

Also on site :

• Governor Hochul: Annual statewide donation drive is complete
• Tornado warning issued, and quickly cancelled, over Alhambra
• Skier dies in collision with tree at Colorado’s Aspen Mountain, resort officials confirm